FATE THERAPEUTICS INC Property, Plant and Equipment, Gross
FATE THERAPEUTICS INC (FATE) had Property, Plant and Equipment, Gross of $93.15 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-26
- 2025-12-31: Property, Plant and Equipment, Gross $93.15M.
- 2024-12-31: Property, Plant and Equipment, Gross $99.52M.
- 2023-12-31: Property, Plant and Equipment, Gross $144.46M.
- 2022-12-31: Property, Plant and Equipment, Gross $140.40M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $93.15M 10-K · filed 2026-02-26 |
| 2024-12-31 | $99.52M 10-K · filed 2026-02-26 |
| 2023-12-31 | $144.46M 10-K · filed 2025-03-05 |
| 2022-12-31 | $140.40M 10-K · filed 2024-02-26 |
| 2021-12-31 | $108.47M 10-K · filed 2023-02-28 |
| 2020-12-31 | $43.40M 10-K · filed 2022-02-28 |
| 2019-12-31 | $19.94M 10-K · filed 2021-02-24 |
| 2018-12-31 | $11.45M 10-K · filed 2020-03-02 |
| 2017-12-31 | $7.69M 10-K · filed 2019-03-05 |
| 2016-12-31 | $5.78M 10-K · filed 2018-03-05 |
| 2015-12-31 | $5.63M 10-K · filed 2017-03-16 |
| 2014-12-31 | $3.99M 10-K · filed 2016-03-03 |
| 2013-12-31 | $3.11M 10-K · filed 2015-03-12 |
| 2012-12-31 | $2.91M 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |